Australia markets closed

Dr Reddy's Laboratories Ltd (RDDA.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
67.000.00 (0.00%)
As of 08:08AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
55,684,000
55,684,000
45,067,000
23,568,000
17,238,000
-
Depreciation & amortisation
14,841,000
14,841,000
12,636,000
11,824,000
12,796,000
-
Deferred income taxes
16,186,000
16,186,000
15,300,000
8,730,000
9,175,000
-
Stock-based compensation
407,000
407,000
397,000
592,000
584,000
-
Change in working capital
-20,182,000
-20,182,000
-7,855,000
-18,498,000
-10,718,000
-
Accounts receivable
-8,054,000
-
-
-
-
-
Inventory
-18,445,000
-18,445,000
-2,654,000
-9,912,000
-12,402,000
-
Accounts payable
3,460,000
-
-
-
-
-
Other working capital
17,998,000
17,998,000
40,009,000
9,059,000
23,142,000
-
Other non-cash items
-567,000
-567,000
248,000
-7,000
144,000
-
Net cash provided by operating activities
45,433,000
45,433,000
58,875,000
28,108,000
35,703,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-27,435,000
-27,435,000
-18,866,000
-19,049,000
-12,561,000
-
Acquisitions, net
-12,000
-12,000
0
-326,000
-15,514,000
-
Purchases of investments
-145,488,000
-145,488,000
-136,171,000
-88,972,000
-75,418,000
-
Sales/maturities of investments
129,784,000
129,784,000
112,805,000
77,771,000
79,528,000
-
Net cash used for investing activities
-40,283,000
-40,283,000
-41,373,000
-26,387,000
-22,660,000
-
Cash flows from financing activities
Debt repayment
-4,947,000
-4,947,000
-1,015,000
-785,000
-4,497,000
-
Common stock issued
805,000
805,000
368,000
334,000
269,000
-
Common stock repurchased
-
-
-
0
-1,193,000
-474,000
Dividends paid
-6,648,000
-6,648,000
-4,979,000
-4,146,000
-4,147,000
-
Net cash used provided by (used for) financing activities
-3,763,000
-3,763,000
-26,861,000
-2,422,000
-298,000
-
Net change in cash
1,387,000
1,387,000
-9,359,000
-701,000
12,745,000
-
Cash at beginning of period
5,779,000
5,779,000
14,852,000
14,820,000
1,962,000
-
Cash at end of period
7,107,000
7,107,000
5,779,000
14,852,000
14,820,000
-
Free cash flow
Operating cash flow
45,433,000
45,433,000
58,875,000
28,108,000
35,703,000
-
Capital expenditure
-27,435,000
-27,435,000
-18,866,000
-19,049,000
-12,561,000
-
Free cash flow
17,998,000
17,998,000
40,009,000
9,059,000
23,142,000
-